no I don’t think so. AEI tested against a surrogate same as ZNO
based on right now 1.2m a month bottling capacity will make $122m annual revenue (they stated previously 200k capacity was $1.7m revenue a month) They refer to a number of other material distribution deals in new parts of the globe so I am expecting a similar volume capacity to be announced for Europe and potentially Arab states. We know they are discussing Australia.
so HCT from current 26m market cap could within months be making $200m-$300m revenue.
that is very nice upside. The stuff can be pumped through buildings to kill the virus in the air. The balm will sell as many as they can make as will not have competition like sanitizers. They are applying for patent.
The virus test will lock in the rerate floor and from there this stock I think will be a monster. They actually have already tested successfully against other corona virus surrogates so as good as what ZNO have done already.
- Forums
- ASX - By Stock
- HCT
- Ann: US Distributor for Natshield sanitiser appointed with sales
Ann: US Distributor for Natshield sanitiser appointed with sales, page-126
-
-
- There are more pages in this discussion • 649 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HCT (ASX) to my watchlist
|
|||||
Last
2.2¢ |
Change
-0.001(4.35%) |
Mkt cap ! $6.133M |
Open | High | Low | Value | Volume |
2.2¢ | 2.2¢ | 2.2¢ | $968 | 43.99K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9 | 2.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.8¢ | 599999 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 9 | 0.022 |
1 | 21214 | 0.021 |
1 | 50000 | 0.020 |
1 | 2500 | 0.018 |
1 | 9829 | 0.017 |
Price($) | Vol. | No. |
---|---|---|
0.028 | 599999 | 2 |
0.029 | 128000 | 3 |
0.030 | 112000 | 2 |
0.039 | 668200 | 2 |
0.040 | 551000 | 2 |
Last trade - 11.25am 10/09/2024 (20 minute delay) ? |
Featured News
HCT (ASX) Chart |